Stem Cell–Based Innovations in Oncology & Advanced Wound Healing

Transforming complex disease treatment through science-driven regenerative solutions.

Who We Are

We are a biotechnology company specialising in stem cell–based innovations in oncology and advanced wound healing. Rooted in scientific expertise and inspired by innovation, we are dedicated to transforming how complex diseases are treated. To expand our global research footprint and accelerate the translation of stem cell discoveries into real-world therapies, we have established OCT Biopharma Inc. in Moncton, New Brunswick, as a 100% subsidiary of OCT Therapies and Research Pvt. Ltd.- our India-based parent company.

Our work focuses on harnessing the therapeutic potential of stem cells to develop next-generation solutions for cancer care and tissue repair. By combining rigorous research, cutting-edge technologies, and global scientific collaborations, we aim to accelerate breakthroughs that improve patient outcomes and elevate standards of care.

With our expansion into Canada, we are committed to contributing to Atlantic Canada’s growing life sciences ecosystem while advancing high-impact biomedical research that bridges innovation between India and North America.

Advanced Wound Care For Oral Muscositis

Oral mucositis (OM) is a prevalent & distressing side effect of cancer treatment that significantly impacts patients' well-being, quality of life, and ability to tolerate therapy. In cancer patients, OM is linked to poor outcomes.

Problem

  • Oral mucositis affects 80% of patients undergoing chemotherapy or radiotherapy

  • Severe cases lead to pain, difficulty swallowing, and treatment delays

Solution

  • MSC-Conditioned Media enables faster healing

  • Supports uninterrupted cancer treatment

Growth factors & cytokines play a role in tissue regeneration.

Addressing Cancer Treatment Side Effects

  • Oral mucositis affects 80% of patients undergoing chemo/radiotherapy
  • Severe cases lead to pain, difficulty swallowing, and treatment delays
  • MSC-Conditioned Media enables faster healing and supports uninterrupted treatment

Harnessing the Power of MSC-Conditioned Media

  • Regenerative and anti-inflammatory properties
  • Immunomodulatory & cell-signaling molecules accelerate healing
  • Non-invasive, user-friendly solution for advanced wound care

Oral Mucositis -
Clinical Trials

We are entering into first in-human clinical trials.

Safety Studies

MSC-derived CM gels tested for healing potential and safety in various wound types

Genetic and systemic safety confirmed: MSC-CM non-mutagenic and well-tolerated

Topical MSC-CM effective in chemotherapy and radiation-induced wounds with regeneration

Regenerative approach for an unmet need in Cancer

First of its kind topical
self-administration

Cell-free alternative to
transplantation for
chemotherapy and radiation
wound healing

Bio-compatible, safe
and efficacious